F. Cavalli

630 total citations
28 papers, 418 citations indexed

About

F. Cavalli is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, F. Cavalli has authored 28 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Public Health, Environmental and Occupational Health and 6 papers in Pathology and Forensic Medicine. Recurrent topics in F. Cavalli's work include Lymphoma Diagnosis and Treatment (5 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Cancer Treatment and Pharmacology (4 papers). F. Cavalli is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Cancer Treatment and Pharmacology (4 papers). F. Cavalli collaborates with scholars based in Switzerland, Belgium and Italy. F. Cavalli's co-authors include Cristiana Sessa, Olivia Pagani, Michele Tomamichel, J. de Jong, Stefan Herzig, Alessandra Sala, P Gertsch, L Riva, M. Bogen and A. Flores and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

F. Cavalli

26 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Cavalli Switzerland 11 203 119 103 74 68 28 418
Helen Angus New Zealand 8 172 0.8× 206 1.7× 77 0.7× 71 1.0× 80 1.2× 13 430
Kim Schmit-Pokorny United States 13 114 0.6× 232 1.9× 65 0.6× 24 0.3× 188 2.8× 22 570
Rachel Hollis United Kingdom 10 121 0.6× 82 0.7× 200 1.9× 52 0.7× 78 1.1× 25 419
Francisco Pedrosa Brazil 15 388 1.9× 151 1.3× 335 3.3× 30 0.4× 87 1.3× 32 673
Federico Antillón United States 15 531 2.6× 211 1.8× 591 5.7× 75 1.0× 57 0.8× 26 858
Brionna Y. Hair United States 10 87 0.4× 260 2.2× 36 0.3× 80 1.1× 26 0.4× 25 498
Anna Moseley United States 11 195 1.0× 286 2.4× 54 0.5× 72 1.0× 36 0.5× 34 606
Isra Levy Canada 13 102 0.5× 171 1.4× 89 0.9× 87 1.2× 24 0.4× 20 558
Anh Minh Nguyen Australia 15 143 0.7× 86 0.7× 165 1.6× 53 0.7× 20 0.3× 38 731
S Haidas United States 9 140 0.7× 66 0.6× 122 1.2× 46 0.6× 14 0.2× 18 415

Countries citing papers authored by F. Cavalli

Since Specialization
Citations

This map shows the geographic impact of F. Cavalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Cavalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Cavalli more than expected).

Fields of papers citing papers by F. Cavalli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Cavalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Cavalli. The network helps show where F. Cavalli may publish in the future.

Co-authorship network of co-authors of F. Cavalli

This figure shows the co-authorship network connecting the top 25 collaborators of F. Cavalli. A scholar is included among the top collaborators of F. Cavalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Cavalli. F. Cavalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bogen, M., et al.. (2009). Randomised comparison of complications from three different permanent central venous access systems. Swiss Medical Weekly. 139(2122). 313–313. 39 indexed citations
2.
Martinelli, Giovanni, Emilia Cocorocchio, Piercarlo Saletti, et al.. (2003). Efficacy of Vinblastine, Bleomycin, Methotrexate (VBM) Combination Chemotherapy with Involved Field Radiotherapy in Early Stage (I-IIA) Hodgkin Disease Patients. Leukemia & lymphoma. 44(11). 1919–1923. 8 indexed citations
3.
Tomamichel, Michele, Herlinda Bonilla Jaime, J. de Jong, et al.. (2000). Proposing phase I studies: Patients', relatives', nurses' and specialists' perceptions. Annals of Oncology. 11(3). 289–294. 25 indexed citations
4.
Masera, Giuseppe, Andrea Biondi, F. Cavalli, et al.. (1998). North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. The Lancet. 352(9144). 1923–1926. 79 indexed citations
5.
Sessa, Cristiana, et al.. (1998). Palliative care of cancer patients: audit of current hospital procedures. Supportive Care in Cancer. 6(3). 266–272.
6.
Bosch, Sandra van den, et al.. (1998). High-dose sequential chemotherapy with autologous blood stem cell rescue for relapsed or resistant lymphoma.. PubMed. 128(40). 1500–7. 1 indexed citations
7.
Neuenschwander, H., et al.. (1997). [Palliative home care in Tessin--an example: Lugano Hospice].. PubMed. 117(3). 261–4. 1 indexed citations
8.
Conter, Valentino, A. Flores, C. Pacheco, et al.. (1997). Treatment of childhood Hodgkin’s disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua. Annals of Oncology. 8(3). 247–250. 43 indexed citations
9.
Colleoni, Marco, Rossella Graffeo, Giulia Martinelli, et al.. (1997). Cisplatin, etoposide and bleomycin infusion (PEBi regimen) in good-risk patients with germ cell tumors. Oncology Reports. 4(5). 913–6. 1 indexed citations
10.
Sessa, Cristiana, Enrico Roggero, S. Pampallona, et al.. (1996). The last 3 months of life of cancer patients: Medical aspects and role of home-care services in southern Switzerland. Supportive Care in Cancer. 4(3). 180–185. 36 indexed citations
11.
Tomamichel, Michele, Cristiana Sessa, Stefan Herzig, et al.. (1995). Informed consent for phase I studies: Evaluation of quantity and quality of information provided to patients. Annals of Oncology. 6(4). 363–369. 59 indexed citations
12.
Boogaerts, M., F. Cavalli, H. Cortés-Funes, et al.. (1995). Granulocyte growth factors: Achieving a consensus. Annals of Oncology. 6(3). 237–244. 24 indexed citations
13.
14.
Beer, M., et al.. (1983). Vincristine overdose: treatment with and without leucovorin rescue.. PubMed. 67(7-8). 746–7. 3 indexed citations
15.
Mulder, J.H., P. Dodion, F. Cavalli, et al.. (1982). Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study. European Journal of Cancer and Clinical Oncology. 18(12). 1297–1301. 10 indexed citations
16.
Cavalli, F., W. F. Jungi, & Kurt Brunner. (1981). Randomisierte Phase-II-Studie mit VP-16–213 (Etoposide®) in der Behandlung vom fortgeschrittenen Mammakarzinom. Oncology Research and Treatment. 4(2). 80–83. 12 indexed citations
17.
Cavalli, F., Marcel Rozencweig, J. Renard, Aron Goldhirsch, & Heine H. Hansen. (1981). Phase II study of oral VP-16-213 in hepatocellular carcinoma. European Journal of Cancer and Clinical Oncology. 17(10). 1079–1082. 26 indexed citations
18.
Cavalli, F., et al.. (1978). Die Kombination von Adriamycin undcis-Diamino-dichloro-platin (II) in der Behandlung therapieresistenter, fortgeschrittener Ovarialkarzinome. DMW - Deutsche Medizinische Wochenschrift. 103(22). 927–931. 5 indexed citations
19.
Cavalli, F., et al.. (1978). [Bladder carcinoma associated with long-term treatment with cyclophosphamide for multiple myeloma (author's transl)].. PubMed. 17(2). 105–8. 4 indexed citations
20.
Cavalli, F., et al.. (1978). Neue Substanzen in der onkologischen Therapie. DMW - Deutsche Medizinische Wochenschrift. 103(27). 1087–1092. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Angus Breakdown of academic impact, for papers by Kim Schmit-Pokorny Breakdown of academic impact, for papers by Rachel Hollis Breakdown of academic impact, for papers by Francisco Pedrosa Breakdown of academic impact, for papers by Federico Antillón Breakdown of academic impact, for papers by Brionna Y. Hair Breakdown of academic impact, for papers by Anna Moseley Breakdown of academic impact, for papers by Isra Levy Breakdown of academic impact, for papers by Anh Minh Nguyen Breakdown of academic impact, for papers by S Haidas
Rankless by CCL
2026